| Literature DB >> 24690471 |
Andreu Nolasco1, José Antonio Quesada, Joaquín Moncho, Inmaculada Melchor, Pamela Pereyra-Zamora, Nayara Tamayo-Fonseca, Miguel Angel Martínez-Beneito, Oscar Zurriaga.
Abstract
BACKGROUND: While research continues into indicators such as preventable and amenable mortality in order to evaluate quality, access, and equity in the healthcare, it is also necessary to continue identifying the areas of greatest risk owing to these causes of death in urban areas of large cities, where a large part of the population is concentrated, in order to carry out specific actions and reduce inequalities in mortality. This study describes inequalities in amenable mortality in relation to socioeconomic status in small urban areas, and analyses their evolution over the course of the periods 1996-99, 2000-2003 and 2004-2007 in three major cities in the Spanish Mediterranean coast (Alicante, Castellón, and Valencia).Entities:
Mesh:
Year: 2014 PMID: 24690471 PMCID: PMC3983886 DOI: 10.1186/1471-2458-14-299
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Frequencies and percentages (by city and sex), classification codes ICD-9 and ICD-10, and age range for the amenable causes studied
| | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Intestinal infections | | | | M | 0 | 0.0 | 1 | 0.1 | 2 | 0.0 |
| 002-009 | A00-A09 | 0-14 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 2 | Tuberculosis | 010-018, | A15-A19, | | M | 25 | 1.6 | 11 | 1.4 | 41 | 0.9 |
| 137 | B90 | 0-74 | F | 4 | 0.3 | 4 | 0.6 | 12 | 0.3 | ||
| 3 | Other infections (diphtheria, tetanus, poliomyelitis) | 032 | A36, A35, | | M | 0 | 0.0 | 0 | 0.0 | 2 | 0.0 |
| 037, 045 | A80 | 0-74 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 4 | Whooping cough | | | | M | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 033 | A37 | 0-14 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 5 | Septicaemia | | | | M | 58 | 3.7 | 13 | 1.7 | 115 | 2.5 |
| 038 | A40-A41 | 0-74 | F | 22 | 1.8 | 9 | 1.4 | 70 | 2.0 | ||
| 6 | Measles | | | | M | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 055 | B05 | 1-14 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 7 | Malignant neoplasm of colon and rectum | | | | M | 269 | 17.3 | 144 | 18.8 | 846 | 18.7 |
| 153-154 | C18-C21 | 0-74 | F | 201 | 16.2 | 114 | 18.1 | 508 | 14.4 | ||
| 8 | Malignant neoplasm of skin | | | | M | 3 | 0.2 | 0 | 0.0 | 14 | 0.3 |
| 173 | C44 | 0-74 | F | 3 | 0.2 | 1 | 0.2 | 4 | 0.1 | ||
| 9 | Malignant neoplasm of breast | | | | M | 2 | 0.1 | 0 | 0.0 | 4 | 0.1 |
| 174 | C50 | 0-74 | F | 317 | 25.5 | 140 | 22.2 | 950 | 26.9 | ||
| 10 | Malignant neoplasm of cervix uteri | | | | M | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 180 | C53 | 0-74 | F | 38 | 3.1 | 21 | 3.3 | 118 | 3.3 | ||
| 11 | Malignant neoplasm of cervix uteri and body uterus | | | | M | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 179, 182 | C54-C55 | 0-44 | F | 2 | 0.2 | 0 | 0.0 | 4 | 0.1 | ||
| 12 | Malignant neoplasm of testis | | | | M | 3 | 0.2 | 1 | 0.1 | 7 | 0.2 |
| 186 | C62 | 0-74 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 13 | Hodgkin’s disease | | | | M | 6 | 0.4 | 3 | 0.4 | 13 | 0.3 |
| 201 | C81 | 0-74 | F | 2 | 0.2 | 4 | 0.6 | 18 | 0.5 | ||
| 14 | Leukaemia | | | | M | 12 | 0.8 | 10 | 1.3 | 50 | 1.1 |
| 204-208 | C91-C95 | 0-44 | F | 11 | 0.9 | 5 | 0.8 | 23 | 0.7 | ||
| 15 | Diseases of the thyroid | | | | M | 3 | 0.2 | 1 | 0.1 | 1 | 0.0 |
| 240-246 | E00-E07 | 0-74 | F | 6 | 0.5 | 1 | 0.2 | 13 | 0.4 | ||
| 16 | Diabetes | | | | M | 7 | 0.5 | 5 | 0.7 | 19 | 0.4 |
| 250 | E10-E14 | 0-49 | F | 2 | 0.2 | 1 | 0.2 | 6 | 0.2 | ||
| 17 | Epilepsy | | | | M | 8 | 0.5 | 4 | 0.5 | 22 | 0.5 |
| 345 | G40-G41 | 0-74 | F | 4 | 0.3 | 3 | 0.5 | 21 | 0.6 | ||
| 18 | Chronic rheumatic heart disease | | | | M | 21 | 1.4 | 10 | 1.3 | 70 | 1.5 |
| 393-398 | I05-I09 | 0-74 | F | 36 | 2.9 | 34 | 5.4 | 148 | 4.2 | ||
| 19 | Hypertensive disease | | I10-I13, | | M | 37 | 2.4 | 23 | 3.0 | 99 | 2.2 |
| 401-405 | I15 | 0-74 | F | 31 | 2.5 | 20 | 3.2 | 89 | 2.5 | ||
| 20 | Ischaemic heart disease: 50% of deaths | | | | M | 510 | 32.9 | 234 | 30.6 | 1366 | 30.2 |
| 410-414 | I20-I25 | 0-74 | F | 185 | 14.9 | 79 | 12.5 | 394 | 11.2 | ||
| 21 | Cerebrovascular diseases | | | | M | 352 | 22.7 | 205 | 26.8 | 1059 | 23.4 |
| 430-438 | I60-I69 | 0-74 | F | 238 | 19.2 | 116 | 18.4 | 719 | 20.4 | ||
| 22 | All respiratory diseases | 460-479, | J00-J09, | | M | 0 | 0.0 | 1 | 0.1 | 3 | 0.1 |
| 488-519 | J20-J99 | 1-14 | F | 0 | 0.0 | 0 | 0.0 | 3 | 0.1 | ||
| 23 | Influenza | | | | M | 0 | 0.0 | 0 | 0.0 | 2 | 0.0 |
| 487 | J10-J11 | 0-74 | F | 0 | 0.0 | 0 | 0.0 | 7 | 0.2 | ||
| 24 | Pneumonia | | | | M | 84 | 5.4 | 35 | 4.6 | 351 | 7.8 |
| 480-486 | J12-J18 | 0-74 | F | 34 | 2.7 | 17 | 2.7 | 157 | 4.4 | ||
| 25 | Peptic ulcer | | | | M | 24 | 1.5 | 6 | 0.8 | 48 | 1.1 |
| 531-533 | K25-K27 | 0-74 | F | 7 | 0.6 | 4 | 0.6 | 13 | 0.4 | ||
| 26 | Appendicitis | | | | M | 1 | 0.1 | 2 | 0.3 | 8 | 0.2 |
| 540-543 | K35-K38 | 0-74 | F | 1 | 0.1 | 1 | 0.2 | 4 | 0.1 | ||
| 27 | Abdominal hernia | | | | M | 1 | 0.1 | 3 | 0.4 | 8 | 0.2 |
| 550-553 | K40-K46 | 0-74 | F | 1 | 0.1 | 3 | 0.5 | 15 | 0.4 | ||
| 28 | Cholelithiasis and cholecystitis | | | | M | 8 | 0.5 | 9 | 1.2 | 30 | 0.7 |
| 574-575.1 | K80-K81 | 0-74 | F | 6 | 0.5 | 5 | 0.8 | 22 | 0.6 | ||
| 29 | Nephritis and nephrosis | | N00-N07, | | M | 66 | 4.3 | 22 | 2.9 | 188 | 4.2 |
| 580-589 | N17-N19, N25-N27 | 0-74 | F | 46 | 3.7 | 21 | 3.3 | 97 | 2.7 | ||
| 30 | Benign prostatic hyperplasia | | | | M | 1 | 0.1 | 0 | 0.0 | 2 | 0.0 |
| 600 | N40 | 0-74 | F | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||
| 31 | Maternal death | | | | M | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 630-676 | O00-O99 | All | F | 2 | 0.2 | 0 | 0.0 | 3 | 0.1 | ||
| 32 | Congenital cardiovascular anomalies | | | | M | 15 | 1.0 | 9 | 1.2 | 52 | 1.1 |
| 745-747 | Q20-Q28 | 0-74 | F | 15 | 1.2 | 9 | 1.4 | 39 | 1.1 | ||
| 33 | Perinatal deaths | | P00-P96, | | M | 34 | 2.2 | 12 | 1.6 | 101 | 2.2 |
| 760-779 | A33, A34 | All | F | 26 | 2.1 | 17 | 2.7 | 72 | 2.0 | ||
| 34 | Misadventures to patients | E870-E876, | Y60-Y69, | | M | 1 | 0.1 | 0 | 0.0 | 4 | 0.1 |
| E878-E879 | Y83-Y84 | All | F | 2 | 0.2 | 1 | 0.2 | 2 | 0.1 | ||
| | TOTAL AMENABLE | | | | M | 1551 | 100.0 | 764 | 100.0 | 4527 | 100.0 |
| F | 1242 | 100.0 | 630 | 100.0 | 3531 | 100.0 | |||||
Number of Census Tracts (CTs) and population of 2001 (Pop) by SES level, and frequencies and percentages of death due to amenable mortality (AM) in comparison to total mortality (TM), by sex, period, and city
| | | | ||||||||||||||
| Alicante | 15 | 21404 | 180 | 218224 | 20 | 22856 | AM | M | 551 | 11.8 | 525 | 10.7 | 475 | 9.8 | 1551 | 10.7 |
| | | | | | | | | F | 471 | 11.6 | 393 | 9.5 | 378 | 8.7 | 1242 | 9.9 |
| | | | | | | | TM | M | 4682 | 100.0 | 4893 | 100.0 | 4854 | 100.0 | 14429 | 100.0 |
| | | | | | | | | F | 4046 | 100.0 | 4158 | 100.0 | 4366 | 100.0 | 12570 | 100.0 |
| Castellón | 6 | 10266 | 84 | 118144 | 5 | 8418 | AM | M | 304 | 12.0 | 220 | 8.5 | 240 | 9.3 | 764 | 9.9 |
| | | | | | | | | F | 230 | 10.9 | 191 | 8.6 | 209 | 9.3 | 630 | 9.6 |
| | | | | | | | TM | M | 2542 | 100.0 | 2598 | 100.0 | 2583 | 100.0 | 7723 | 100.0 |
| | | | | | | | | F | 2107 | 100.0 | 2232 | 100.0 | 2253 | 100.0 | 6592 | 100.0 |
| Valencia | 53 | 62859 | 456 | 576146 | 44 | 49370 | AM | M | 1693 | 11.6 | 1502 | 10.6 | 1332 | 9.6 | 4527 | 10.6 |
| | | | | | | | | F | 1351 | 10.3 | 1155 | 8.7 | 1025 | 7.4 | 3531 | 8.8 |
| | | | | | | | TM | M | 14578 | 100.0 | 14109 | 100.0 | 13931 | 100.0 | 42618 | 100.0 |
| F | 13177 | 100.0 | 13293 | 100.0 | 13870 | 100.0 | 40340 | 100.0 | ||||||||
Figure 1Geographical distribution of the Socioeconomic Status (SES) according to census tracts in Alicante, Castellón and Valencia.
Specific rates (x100.000) of amenable mortality by sex, period, age, socioeconomic status level (SES), and city
| 1996-99 | SES1 | 13,1 | 131,4 | 717,7 | 24,4 | 112,1 | 420,2 | 19,1 | 162,2 | 568,6 |
| SES2 | 24,8 | 171,4 | 730,5 | 22,5 | 209,5 | 832,4 | 23,3 | 223,9 | 781,9 | |
| SES3 | 13,4 | 214,4 | 877,8 | 8,0 | 272,6 | 881,5 | 33,2 | 259,9 | 819,7 | |
| 2000-03 | SES1 | 12,7 | 108,2 | 624,3 | 6,2 | 175,5 | 493,9 | 20,6 | 136,1 | 614,3 |
| SES2 | 17,5 | 162,0 | 680,2 | 15,6 | 115,6 | 575,7 | 21,7 | 177,7 | 673,8 | |
| SES3 | 28,2 | 185,9 | 667,7 | 23,5 | 167,7 | 687,8 | 36,6 | 189,6 | 754,3 | |
| 2004-07 | SES1 | 9,9 | 80,4 | 437,4 | 17,1 | 64,5 | 482,2 | 23,1 | 121,2 | 550,8 |
| SES2 | 16,7 | 140,4 | 564,8 | 18,0 | 145,3 | 560,1 | 19,9 | 155,9 | 570,1 | |
| | SES3 | 23,7 | 223,7 | 583,4 | 18,0 | 247,0 | 257,1 | 26,6 | 267,8 | 565,7 |
| | ||||||||||
| 1996-99 | SES1 | 22,2 | 121,3 | 205,6 | 6,6 | 109,6 | 411,2 | 22,1 | 85,1 | 304,9 |
| SES2 | 20,9 | 145,1 | 466,1 | 19,5 | 133,6 | 496,0 | 25,0 | 141,1 | 448,5 | |
| SES3 | 17,1 | 179,7 | 518,2 | 32,3 | 235,1 | 738,5 | 16,1 | 192,4 | 494,1 | |
| 2000-03 | SES1 | 9,1 | 50,0 | 361,0 | 18,0 | 89,2 | 252,3 | 27,4 | 105,0 | 342,1 |
| SES2 | 15,7 | 118,3 | 346,1 | 18,0 | 125,7 | 336,5 | 22,6 | 110,4 | 355,2 | |
| SES3 | 27,9 | 121,9 | 613,6 | 16,2 | 182,0 | 462,2 | 18,0 | 175,5 | 468,3 | |
| 2004-07 | SES1 | 22,0 | 71,6 | 182,3 | 19,3 | 53,4 | 485,7 | 10,8 | 82,9 | 283,0 |
| SES2 | 15,3 | 117,4 | 316,9 | 19,0 | 100,3 | 388,2 | 20,5 | 110,5 | 306,5 | |
| SES3 | 22,6 | 158,2 | 332,8 | 30,8 | 84,6 | 643,2 | 17,6 | 113,1 | 403,9 | |
Figure 2Evolution of Age Standardised Rate (Log(ARS)) by socioeconomic status (SES), city, and sex.
Adjusted Relative Risks (RR) of death and confidence intervals at 95% for age, period, and socioeconomic status, according to city and sex
| | | ||
|---|---|---|---|
| ALICANTE | |||
| Age | 00-49 | 1 | 1 |
| 50-64 | |||
| 65-74 | |||
| Period | 96-99 | 1 | 1 |
| 00-03 | 0.9 (0.8-1.0) | ||
| 04-07 | |||
| SES | SES1 | 1 | 1 |
| SES2 | 1.3 (1.0-1.6) | ||
| SES3 | |||
| CASTELLÓN | |||
| Age | 00-49 | 1 | 1 |
| 50-64 | |||
| 65-74 | |||
| Period | 96-99 | 1 | 1 |
| 00-03 | |||
| 04-07 | |||
| SES | SES1 | 1 | 1 |
| SES2 | 1.3 (0.9-1.7) | 1.1 (0.8-1.6) | |
| SES3 | 1.4 (0.9-2.1) | ||
| VALENCIA | |||
| Age | 00-49 | 1 | |
| 50-64 | (**) | ||
| 65-74 | | ||
| Period | 96-99 | 1 | 1 |
| 00-03 | |||
| 04-07 | |||
| SES | SES1 | 1 | |
| SES2 | (**) | ||
| SES3 | | ||
| (**) 00-49 | SES1 | | 1 |
| SES2 | | 1.1 (0.9-1.5) | |
| SES3 | | 0.9 (0.6-1.3) | |
| (**) 50-64 | SES1 | | 1 |
| SES2 | | ||
| SES3 | | ||
| (**) 65-74 | SES1 | | 1 |
| SES2 | | 1.2 (1.0-1.4) | |
| SES3 | |||
(*) In bold, RR are statistically significant at 95%.
(**) Owing to the existence of significant interaction between age and SES for women, the RRs for the SES are shown in each of the age groups.